Zonisamide add-on therapy for focal epilepsy-Reference-Cited by-同舟云学术

Zonisamide add-on therapy for focal epilepsy

Published:2018-10-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Brigo Francesco¹,Lattanzi Simona²,Igwe Stanley C³,Behzadifar Masoud⁴,Bragazzi Nicola Luigi⁵

Affiliation:

1. University of Verona; Department of Neurosciences, Biomedicine and Movement Sciences; P.le L.A. Scuro, 10 Verona Verona Italy 37134

2. Marche Polytechnic University; Neurological Clinic; Ancona Italy

3. Federal Teaching Hospital; Department of Neuropsychiatry; Abakaliki Ebonyi State Nigeria 48000

4. Lorestan University of Medical Sciences; Social Determinants of Health Research Center; Khorramabad Iran

5. Postgraduate School of Public Health; Department of Health Sciences; University of Genoa Genoa Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001416.pub4/epdf/full

Reference42 articles.

1. Dose-dependent safety and efficacy of zonisamide in refractory, localization-related epilepsy: a randomized, double-blind, placebo-controlled trial;Brodie;Epilepsia,2004

2. Zonisamide is a effective adjunctive therapy for patients with refractory partial epilepsy: results from a randomised, double-blind, placebo-controlled study;Brodie;Epilepsia,2004

3. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures;Brodie;Epilepsia,2005

4. Efficacy of zonisamide against refractory partial seizures in an evaluable patient population;Brodie;Epilepsia,2005

5. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures;Faught;Neurology,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Equity Consideration in Cochrane Systematic Reviews and Primary Studies on Add-on Therapy for Refractory Focal Epilepsy Treatment;Archives Of Epilepsy;2024-06-13

2. Efficacy and safety of zonisamide as the first additional treatment in Chinese patients with focal or secondary bilateral tonic–clonic seizures: An observational ,prospective study;Heliyon;2023-07

3. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies;CNS Drugs;2022-10

4. Eficacia de la zonisamida en un caso de enfermedad de Lafora y breve revisión en la epilepsia mioclónica progresiva;Revista de Neurología;2022

5. Anti-convulsant Agents: Zonisamide;NeuroPsychopharmacotherapy;2022